|
⚲
|
| Keyboard |
| Galecto Inc | |
|---|---|
| Ticker | DMRA |
| CIK # | 0001800315 |
| CUSIP | 36322Q206 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | Galecto Biotech Ab Ole Maaloes Vej3, Copenhagen, DK-2200 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Galecto Inc | 2025-11-21 | 285.0 M | Exemption: 506(b) · Duration: One year or less · Finder's Fee: $17,100,000 · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001800315] | 10-K | |
| [0001800315] | 10-Q | |
| [0001800315] | 3 | |
| [0001800315] | 4 | |
| [0001800315] | 8-K | |
| [0001800315] | D | |
| [0001800315] | SC 13D | |
| [0001800315] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Turtle Cameron
Stock Option (right to buy) · derivative
|
2026-03-23 | Grant | 37,313 | $0.00 | |
|
Bruno Julianne
Stock Option (right to buy) · derivative
|
2026-03-23 | Grant | 37,313 | $0.00 | |
|
Winslow Garrett
Stock Option (right to buy) · derivative
|
2026-03-23 | Grant | 250,000 | $0.00 | |
|
Cain Christopher W
Stock Option (right to buy) · derivative
|
2026-03-23 | Grant | 37,313 | $0.00 | |
|
Kiselak Tomas +4
Stock Option (right to buy) · derivative
|
2026-03-23 | Grant | 37,313 | $0.00 | |
|
Landsittel Michael
Stock Option (right to buy) · derivative
|
2026-03-23 | Grant | 37,313 | $0.00 | |
|
Kiselak Tomas +4
Common Stock
|
2026-02-09 | Option exercise | 5,809,000 | $0.00 | |
|
Kiselak Tomas +4
Common Stock
|
2026-02-09 | Option exercise | 2,904,000 | $0.00 | |
|
Bruno Julianne
Common Stock
|
2026-02-09 | Option exercise | 129,000 | $0.00 | |
|
Bruno Julianne
Series C Preferred Stock · derivative
|
2026-02-09 | Option exercise | 129 | $0.00 | |
|
Kiselak Tomas +4
Series C Preferred Stock · derivative
|
2026-02-09 | Option exercise | 5,809 | $0.00 | |
|
Kiselak Tomas +4
Series C Preferred Stock · derivative
|
2026-02-09 | Option exercise | 2,904 | $0.00 | |
|
Hewes L Becker
Stock Option (right to buy) · derivative
|
2026-01-05 | Grant | 528,603 | $0.00 | |
|
Sattarzadeh Sherwin
Common Stock
|
2026-01-05 | Grant | 190,376 | $0.00 | |
|
Hewes L Becker
Common Stock
|
2026-01-05 | Grant | 264,629 | $0.00 | |
|
Sattarzadeh Sherwin
Stock Option (right to buy) · derivative
|
2026-01-05 | Grant | 444,209 | $0.00 | |
|
Winslow Garrett
Restricted Stock Units · derivative
|
2026-01-02 | Option exercise | 680 | $0.00 | |
|
Firmani Lori
Restricted Stock Units · derivative
|
2026-01-02 | Option exercise | 374 | $0.00 | |
|
Firmani Lori
Common Stock
|
2026-01-02 | Option exercise | 374 | ||
|
Firmani Lori
Common Stock
|
2026-01-02 | Sell | 135 | $21.41 | 2,890 |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 65 | 56,064,965 |
| 2025-12-31 | 18 | 1,107,880 |
| 2025-09-30 | 12 | 170,205 |
| 2025-06-30 | 10 | 132,760 |
| 2025-03-31 | 12 | 142,701 |
| 2024-12-31 | 11 | 142,062 |
| 2024-09-30 | 11 | 128,633 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares | Prev | Page 1 | Next |